X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CELL DEATH AND DIFFERENTIATION

期刊標題檢索 CELL DEATH DIFF 最新評論: Just wanted to ask, was the link provided for redirection in the end? ... (2024-11-19)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CELL DEATH AND DIFFERENTIATION]您好,您是該頁面的第 156856 位訪客。

期刊簡介
期刊名稱CELL DEATH AND DIFFERENTIATION CELL DEATH AND DIFFERENTIATION
LetPub Score
9.0
50 ratings
Rate

Reputation
9.9

Influence
8.7

Speed
7.2

期刊簡稱CELL DEATH DIFFER
ISSN1350-9047
E-ISSN1476-5403
h-index193
CiteScore
CiteScoreSJRSNIPCiteScore Rank
24.704.1022.144
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q111 / 410
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cell Biology
Q113 / 285

自引率 (2023-2024)1.50%自引率趨勢
掲載範囲
Mission, vision and values of CDD:
To devote itself to scientific excellence in the field of cell biology, molecular biology, and biochemistry of cell death and disease.
To provide a unified forum for scientists and clinical researchers
It is committed to the rapid publication of high quality original papers relating to these subjects, together with topical, usually solicited, reviews, meeting reports, editorial correspondence and occasional commentaries on controversial and scientifically informative issues.
官方網站https://www.nature.com/cdd
在線稿件提交https://mts-cdd.nature.com/
開放訪問No
出版商Springer Nature
主題領域生物
出版國/地區ENGLAND
發行頻率月刊
創刊年1997
每年文章數139每年文章數趨勢
黃金OA百分比49.80%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ110/313
CELL BIOLOGYSCIEQ115/205
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1350-9047%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 3.0 month(s)
競爭力 *來自作者的數據: About 80%
參考鏈接
相關期刊 【CELL DEATH AND DIFFERENTIATION】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    TRENDS IN MOLECULAR MEDICINEH-index: 160

    CiteScore: 24.60
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1332248
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS575313
    JOURNAL OF BIOLOGICAL CHEMISTRY396193
    NUCLEIC ACIDS RESEARCH341667
    CELL298588
    FASEB JOURNAL270645
    International Journal of Biological Sciences240986
    PLANT SCIENCE228326
    Molecular Cancer227907
    ONCOGENE203898
  •  

    CELL DEATH AND DIFFERENTIATION CELL DEATH AND DIFFERENTIATION
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/24)
  [CELL DEATH AND DIFFERENTIATION] 的評論撰寫評論
作者: jessica chu


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-11-19 11:15:14 評論於
Just wanted to ask, was the link provided for redirection in the end? I also received suggestions to redirect, but it shows that the link is Redacted, do I need to wait or contact the editorial department?
(0) 讚! | jessica chu

作者: AKAPAN


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-30 15:17:52 評論於
Why am I always being rejected?
(0) 讚! | AKAPAN

作者: 奇颖殿下


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 20:58:48 評論於
After receiving the editor assigned, will there be another step of under review?
(0) 讚! | 奇颖殿下

作者: 奇颖殿下


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 17:39:00 評論於
Is there a step of "under review" after the receiving editor is assigned?
(0) 讚! | 奇颖殿下

作者: 奇颖殿下


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-27 15:25:16 評論於
Will there be a step of "under review" afterwards?
(0) 讚! | 奇颖殿下

作者: 混元庚寅


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-18 13:35:21 評論於
It has been 80 days, the status changed from under consideration to blank and then back to under consideration. What's going on?
(0) 讚! | 混元庚寅

作者: 断刀浩荡


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-10 18:08:02 評論於
Does the Western Union need the original strip?
(0) 讚! | 断刀浩荡

作者: _darktempler


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 17:33:01 評論於
Direction of protein modification, lactylation modification, major revision was given in the first review, with two reviewers, one of whom had no major comments and thought that the research seemed to have sufficiently proved the author's point, and provided two minor comments, while the other reviewer provided some suggestions. It was sent back for revisions for 2 months, waiting for the results of the second review. I hope it can be faster and also wish for good luck, this manuscript has been rejected several times, my heart is truly tired.
(0) 讚! | _darktempler

作者: 极乐彩霞


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-23 14:18:15 評論於
May I ask what you mean by "后续" in English?
(0) 讚! | 极乐彩霞

作者: 夏易baby


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-14 13:56:46 評論於
When will the submission be assigned an editor?
(0) 讚! | 夏易baby

作者: 夏易baby


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-14 11:57:57 評論於
I have also received it, replied to the email, but the editor has not been assigned yet.
(0) 讚! | 夏易baby

作者: 夏易baby


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-13 14:26:46 評論於
When will everyone be assigned editors?
(0) 讚! | 夏易baby

作者: 夏易baby


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 18:03:26 評論於
How are things now?
(0) 讚! | 夏易baby

作者: XLSL


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-30 16:01:10 評論於
I also have been given 4 months for major repairs, some experiments cannot be carried out. How are you doing now?
(0) 讚! | XLSL

作者: 削月莆泽


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-27 13:30:45 評論於
May I ask if you were rejected later on? My submission has been pending for 7 days now... not looking too promising, right?
(0) 讚! | 削月莆泽

作者: Adelaide Lawson


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-18 14:24:45 評論於
The reviewers have completed the review of the manuscript and have submitted their comments to the editorial department. Please check your email for updates.
(0) 讚! | Adelaide Lawson

作者: 迎珊小可爱


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-14 08:28:08 評論於
On the first day of submission, it is under consideration, and a decision is made on the eighth day. What does this mean? Has it been rejected?
(0) 讚! | 迎珊小可爱

作者: 颂歌卢卡斯


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-11 23:42:28 評論於
Research focus: Mechanisms of tumor metastasis
Experience sharing: After submitting the manuscript, what should we do if co-authors did not receive the email notification? Can they still receive it later?
(0) 讚! | 颂歌卢卡斯

作者: 小海宾吖


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-31 20:45:33 評論於
Research focus: Tumor experience sharing: Big CDD requires a clear molecular mechanism, which is highly recognized in the field of oncology. Editors are very fond of p53, ubiquitination, and various new types of cell death-related work. Worth a try.
(1) 讚! | 小海宾吖

作者: 也不容易哦


領域: 生物学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-15 19:09:57 評論於
The submission was made on June 10, 2024, and there has been no response so far.
(0) 讚! | 也不容易哦

作者: 王二哥


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-07-09 08:01:33 評論於
Submission on 2024.07.03, shown as Under Consideration immediately after submission. On 2024.07.04, Research Square displayed Submission checks complete. On 2024.07.05, received an email recommending Receiving Editor, even though Receiving Editor was selected on the submission system, still received this email. Receiving Editor replied from the Editorial Board on the official website, possibly related to the direction. Decision Made on 2024.07.06 (Friday), felt like it was going to be rejected. On 2024.07.08, Reject, suggested to submit to Small CDD. The article was previously submitted to Advance Science, sent for review, received two reviews, one agreed to major revisions, and one rejected, Editor directly rejected it. Submission to Big CDD was almost instantly rejected, not sent for review. Big CDD publishes articles mainly focused on tumors and ubiquitination mechanisms. Overall quality is high, with good reputation and extremely fast review speed. Due to the lower number of published articles, around 100 per year, it is considered small and refined, unlike some domestic journals that rely on reviews to forcibly boost their IF, the review process is stricter and more challenging compared to Advance Science.
(1) 讚! | 王二哥

作者: 璧射初兰


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-04 18:21:26 評論於
It seems to have stopped now, Nature is on strike altogether and the situation remains unchanged.
(0) 讚! | 璧射初兰

作者: 碧水力行


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-26 15:44:09 評論於
May I ask if it's possible?
(0) 讚! | 碧水力行

作者: 削月以松


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-21 20:59:27 評論於
Almost.
(0) 讚! | 削月以松

作者: Micheal-wang


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-19 18:49:37 評論於
May I ask how to proceed next?
(0) 讚! | Micheal-wang

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/24)

開始撰寫 [CELL DEATH AND DIFFERENTIATION] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*